Abstract
Purpose
To identify urologic systematic reviews (SRs) registered to PROSPERO that resulted in a publication, and to evaluate their methodological quality and concordance with their stated a priori protocols.
Methods
We searched PubMed to identify urologic SR protocols registered in PROSPERO that resulted in a publication and assessed their methodological quality and protocols in relation to their stated a priori protocols in PROSPERO.
Results
Of the 576 urologic SR protocols registered in PROSPERO up to December 2017, 201 (34.9%) resulted in a full SR publication, but only 40 (17.7%) updated their registration record accordingly. Publications were spread over 100 different journals, with a median time-to-publication of 29 months (95% CI 25.0–33.0). The most common topic by far was prostate cancer (59.7%), followed by voiding issues (15.3%), and renal transplantation (15.3%). Only little over half the reviews (52.74%) explicitly stated primary outcome(s) that matched the primary outcome of their corresponding PROSPERO protocol. Notable methodologic deviations from registered protocols included planned restriction on study design (33%), heterogeneity analysis (42%) and planned risk of bias analysis (65.2%).
Conclusion
SR authors in urology are increasingly using PROSPERO to register their titles, but our findings indicate that registration alone is not a guarantor of a high-quality SR product. There appears to be a critical need to raise the bar for review authors registering protocols in PROSPERO, with an emphasis on transparency in their publication status updates as well as deviations from their a priori protocols.


Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.References
Canfield SE, Dahm P (2011) Rating the quality of evidence and the strength of recommendations using GRADE. World J Urol 29:311–317. https://doi.org/10.1007/s00345-011-0667-2
Corbyons K, Han J, Neuberger MM, Dahm P (2015) Methodological quality of systematic reviews published in the urological literature from 1998 to 2012. J Urol 194:1374–1379. https://doi.org/10.1016/j.juro.2015.05.085
Han JL, Gandhi S, Bockoven CG et al (2017) The landscape of systematic reviews in urology (1998 to 2015): an assessment of methodological quality. BJU Int 119:638–649. https://doi.org/10.1111/bju.13653
Ioannidis JPA (2016) The mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses. Milbank Q 94:485–514. https://doi.org/10.1111/1468-0009.12210
Shea BJ, Grimshaw JM, Wells GA et al (2007) Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 7:10. https://doi.org/10.1186/1471-2288-7-10
Shea BJ, Reeves BC, Wells G et al (2017) AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ 358:j4008. https://doi.org/10.1136/BMJ.J4008
Moher D, Booth A, Stewart L (2014) How to reduce unnecessary duplication: use PROSPERO. BJOG An Int J Obstet Gynaecol 121:784–786. https://doi.org/10.1111/1471-0528.12657
Page MJ, Shamseer L, Tricco AC (2018) Registration of systematic reviews in PROSPERO: 30,000 records and counting. Syst Rev 7:32. https://doi.org/10.1186/s13643-018-0699-4
Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097. https://doi.org/10.1371/journal.pmed.1000097
Booth A, Clarke M, Dooley G et al (2012) The nuts and bolts of PROSPERO: an international prospective register of systematic reviews. Syst Rev 1:2. https://doi.org/10.1186/2046-4053-1-2
Khaleel S, Sathianathen N, Balaji P, Dahm P (2019) Quality of urological systematic reviews registered in PROSPERO. BJU Int. https://doi.org/10.1111/bju.14742
Borah R, Brown AW, Capers PL, Kaiser KA (2017) Analysis of the time and workers needed to conduct systematic reviews of medical interventions using data from the PROSPERO registry. BMJ Open. https://doi.org/10.1136/bmjopen-2016-012545
Andrade R, Pereira R, Weir A et al (2017) Zombie reviews taking over the PROSPERO systematic review registry. It’s time to fight back! Br J Sports Med. https://doi.org/10.1136/bjsports-2017-098252
Sideri S, Papageorgiou SN, Eliades T (2018) Registration in the international prospective register of systematic reviews (PROSPERO) of systematic review protocols was associated with increased review quality. J Clin Epidemiol. https://doi.org/10.1016/J.JCLINEPI.2018.01.003
Author information
Authors and Affiliations
Contributions
SK: protocol/project development, data collection or management, data analysis, manuscript writing/editing; BC: data collection or management; AK: data collection or management, NS: data collection or management; PB: data collection or management; PD: protocol/project development, data analysis, manuscript writing/editing.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to declare.
Research involving human participants and/or animals
This research project did not involve any human participants and/or animals.
Informed consent
The research protocol did not involve human participants or animals and did not require informed consent.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Khaleel, S., Cleveland, B., Kalapara, A. et al. The fate of urological systematic reviews registered in PROSPERO. World J Urol 38, 2981–2986 (2020). https://doi.org/10.1007/s00345-019-03032-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-019-03032-x